启明星 | 国产GPU领军企业壁仞科技成功登陆香港交易所 | Bilingual

** Swipe Left for the English Version

北京时间2026年1月2日，启明创投投资企业、国产GPU领军企业壁仞科技成功登陆港交所，成为2026年港股首家上市企业。 壁仞科技（06082.HK）发行价为19.6港元/股，开盘价35.7港元/股，市值855.42亿港元。此次成功登陆港交所，壁仞科技不仅为"港股GPU第一股"，也是港股18C章规则落地以来发行规模最大的新股。

启明创投是壁仞科技最早也是最坚定的支持者之一，2019年壁仞科技成立伊始，启明创投就作为创始投资人，领投了公司的第一轮融资，并在后续持续支持公司发展。启明创投不仅是公司最大的外部机构投资人，亦是公司的领航资深独立投资者之一。

壁仞科技创始人、董事长兼CEO张文（左）、启明创投创始主管合伙人邝子平（中）、启明创投主管合伙人周志峰（右）

壁仞科技成立于2019年，是国内领先的通用智能计算解决方案提供商。公司坚持原创核心架构，首创Chiplet大算力芯片，构建软硬协同创新的技术体系，致力于打造国产智能计算产业生态，成为中国人工智能产业发展的核心引擎。

目前，壁仞科技已开发出第一代GPGPU架构及一系列基于GPGPU的硬件，并已成功开发壁砺™106及壁砺™110两款芯片产品以及性能更高的壁砺™166芯片产品，产品应用于AI数据中心、电信、AI解决方案、能源及公用事业、金融科技及互联网等关键行业。

壁仞科技创始人、董事长兼CEO张文表示： "壁仞科技迎来了一个更好的开始，成为一家公众公司，也意味着肩负起更大的责任。未来，壁仞科技将持续加大研发投入，全力推进全栈自主可控产品研发迭代，构建起完善的国产算力体系，着力提升我国智算产业的安全、稳定与坚韧水平，引领并赋能人工智能产业高质量发展。"

启明创投主管合伙人周志峰表示："作为壁仞科技的第一轮创始投资人，我们非常高兴一路并肩同行、见证公司成功上市这一重要里程碑。自创立之初，壁仞科技就选择了一条极具挑战但意义重大的道路—以持续的技术创新，打造高性能通用GPU。壁仞科技的成功上市，不仅是企业自身发展的重要节点，也验证了中国科技创业的主题正逐步迈向以原始技术创新为核心的新阶段。上市是阶段性的成果，更是新征程的起点。期待壁仞科技持续深化技术创新，在构建中国乃至全球AI生态系统中贡献更为重要的作用。"

Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange

Qiming Venture Partners' portfolio company Biren Technology, a leading domestic GPU developer, successfully listed on the Hong Kong Stock Exchange today, becoming the first company to go public in Hong Kong in 2026.

Biren Technology (06082.HK) issued shares at a price of HK$19.6 per share and opened at HK$35.7 per share with a market capitalization of HK$85.54 billion. Biren Technology's successful listing makes it the first GPU stock on the Hong Kong market and the largest new share offering since Chapter 18C took effect.

Qiming Venture Partners is the earliest and most steadfast supporter of Biren Tech. Qiming, as a founding investor, led Biren Technology's first round of financing when the company was founded in 2019, and has continued to fund its development since then. Qiming is the company's largest external institutional investor.

Founded in 2019, Biren Technology is a leading provider of general intelligent computing solutions in China. The company adheres to an original core architecture, pioneers the Chiplet-based high-performnace computing chip, has built a technology system featuring software-hardware co-innovation. It is dedicated to fostering a intelligent computing industry ecosystem and aims to serve as a core engine for the development of China's artificial intelligence industry.

Biren Technology has developed the first-generation General Purpose Graphics Processing Units (GPGPU) architecture and a series of hardware based on GPGPU. It has successfully developed the Biren ™106 and Biren ™110 chips as well as the higher-performing Biren ™166 chip. The chips are used in key industries such as AI data centers, telecommunications, AI solutions, energy and public utilities, fintech and internet.

Zhang Wen, Founder, Chairman and CEO of Biren Technology, stated: "Becoming a public company marks a stronger beginning for Biren—and brings greater responsibility. Going forward, we will continue to increase R&D investment, accelerate the development of our fully independent and controllable product stack, and help build a robust, domestic computing ecosystem. Our aim is to enhance the security, stability, and resilience of China's intelligent computing capabilities, driving and enabling high-quality development across the AI sector."

"As a founding investor in Biren Technology's first financing round, we are delighted to have journeyed alongside the company and witnessed this significant milestone of its successful listing. From the outset, Biren Technology chose a challenging yet critical path—developing high-performance general-purpose GPUs through continuous technological innovation. Its successful listing not only marks a key phase in the company's growth but also demonstrates the evolution of China's tech entrepreneurship towards a new stage centered on original innovation. The listing is both a phased achievement and the starting point of a new journey. We expect Biren Technology to continue deepening its technological innovation and to play an increasingly significant role in building the AI ecosystem in China and globally," said Alex Zhou, Managing Partner of Qiming Venture Partners.

往 期 回 顾

启明观点 | 启明创投周志峰：2025年会是AI应用全面落地的大年 对话 | 壁仞科技：高性能通用GPU支撑中国大模型训练与推理 | 世界人工智能大会 启明荣誉 | 5位启明创投投资人荣登2025年福布斯中国创投人100榜单

启明创投成立于2006年。目前，启明创投旗下管理11只美元基金，7只人民币基金，已募管理资产总额达到95亿美元。自成立至今，专注于投资科技(Technology)、医疗创新(Healthcare)等行业早期和成长期的优秀企业。

截至目前，启明创投已投资超过580家高速成长的创新企业，其中有超过210家分别在美国纽交所、纳斯达克，香港交易所，上交所及深交所等交易所上市，或通过并购等方式退出，有80多家企业成为行业公认的独角兽或超级独角兽企业。

启明创投投资企业中，很多已经成长为各自领域中最具影响力的公司，包括小米集团（01810.HK）、美团（03690.HK）、哔哩哔哩（NASDAQ:BILI, 09626.HK）、知乎（NYSE:ZH, 02390.HK）、石头科技（688169.SH）、禾赛科技（NASDAQ:HSAI,02525.HK）、优必选（09880.HK）、文远知行（NASDAQ:WRD, 00800.HK）、海博思创（688411.SH）、影石创新（688775.SH）、云知声（09678.HK）、壁仞科技（06082.HK）、甘李药业（603087.SH）、泰格医药（300347.SZ, 03347.HK）、再鼎医药（NASDAQ:ZLAB, 09688.HK）、康希诺生物（688185.SH, 06185.HK）、Schrödinger（NASDAQ:SDGR）、惠泰医疗（688617.SH）、三友医疗（688085.SH）、艾德生物（300685.SZ）、神州细胞（688520.SH）、英矽智能（03696.HK）、浩博生物、圆心科技、宜联生物、礼新医药、智谱、阶跃星辰等。